Inhibition of cyclophosphamide-induced teratogenesis by β-ionone

Toxicology Letters

Volumn 138, Issue 3, 2003, Pages 205-213

  Gomes Carneiro, M R ^a   De Oliveira, A C A X ^a   De Carvalho, R R ^a   Araujo, I B ^b   Souza, C A M ^a   Kuriyama, S N ^a   Paumgartten, F J R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cytochrome P450; Developmental toxicity; Essential oils; Metabolic activation; Pentobarbital; Terpenoid compounds

Indexed keywords

BETA IONONE; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2B1; GENUXAL; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; EMBRYOTOXICITY; ENZYME INHIBITION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; SLEEP TIME;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BODY WEIGHT; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP2B1; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; FETAL DEATH; FETAL RESORPTION; HYPNOTICS AND SEDATIVES; MALE; NORISOPRENOIDS; PENTOBARBITAL; PREGNANCY; RATS; RATS, WISTAR; SLEEP; TERPENES;

RATTUS NORVEGICUS;

EID: 0037416745     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00413-7     Document Type: Article

References (17)

1. Banthorpe D.V. Terpenoids. Mann J., Davidson R.S., Hobbs J.B., Banthorpe D.V., Harborne J.B. Natural Products. Their Chemistry and Biological Significance. 1994;289-359 Longman Scientific & Technical, Longman Group, Harlow, UK.
2. Burke M.D., Thompson S., Weaver R.J., Wolf C.R., Mayer T. Cytochrome P450 specificities of alkoxyresorufin-O-dealkylation in human and rat liver. Biochem. Pharmacol. 48:1994;923-936.
3. Chahoud I., Kuriyama S.N., Paumgartten F.J.R. Maternal protein-and-energy restriction reduces the developmental toxicity of cyclophosphamide and hydroxyurea in rats. Toxicology. 179:2002;137-149.
4. De-Oliveira A.C.A.X., Fidalgo-Neto A.A., Paumgartten F.J.R. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol. Toxicology. 135:1999;33-41.
5. Erickson R.E. The industrial importance of monoterpenes and essential oils. Lloydia. 39:1976;8-19.
6. Gibson G.G., Skett P. Introduction to Drug Metabolism. 1994;266 Blackie Academic & Professional, Chapman & Hall, London, Glasgow, New York.
7. Ioannides C., Parke D.V. Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates. J. Pharm. Pharmacol. 27:1975;739-746.
8. Jeong T.C., Jordan S.D., Matulka R.A., Stanulis E.D., Kaminski E.J., Holsapple M.P. Role of metabolism by esterase and cytochrome P450 in cocaine-induced suppression of antibody response. J. Pharmacol. Exp. Ther. 272:1995;407-416.
9. Jeong T.C., Kim H.J., Yun C.H., Lee S.S., Yang K.H., Han S.S., Roh J.K. Induction of liver cytochrome P450 2B1 by beta-ionone in Sprague-Dawley rats. Biochem. Biophys. Res. Commun. 216:1995;198-202.
10. Jeong T.C., Gu H.K., Chun Y.J., Yun C.H., Han S.S., Roh J.K. Effects of beta-ionone on the expression of cytochrome P450s and NADH-cytochrome P450 reductase in Sprague-Dawley rats. Chem. Biol. Interact. 114:1998;97-107.
11. Jeong T.C., Gu H.K., Park J.-I., Yun H.-I., Kim H.-C., Ha C.-S., Roh J.K. Pretreatment of male BALC/c mice with β-ionone potentiates thioacetamide-induced hepatotoxicity. Toxicol. Lett. 105:1999;39-46.
12. Mirkes P.E. Cyclophosphamide teratogenesis: a review. Teratog. Carcinog. Mutag. 5:1985;75-88.
13. Roth L., Harbison R.D., James R.C., Tobin T., Roberts S.M. Cocaine hepatoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology. 15:1992;934-940.
14. Roy P., Yu L.J., Crespi C.L., Waxman D.J. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on c-DNA-expressed activities and liver microsomal P-450 profiles. Drug Metab. Dispos. 27:1999;655-666.
15. Salewski E. Faerbemethoden zum makroskopischen Nachweis von Implantationsstellen am Uterus der Ratte. Naunyn-Schmiedebergs. Arch. Exp. Pathol. Pharmakol. 247:1964;367.
16. Stahlmann R., Bluth U., Neubert D. Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures. Arch. Toxicol. 57:1985;163-167.
17. Yu L.J., Drewes P., Gustafsson K., Hecht J.E.D., Waxman D.J. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity. J. Pharmacol. Exp. Ther. 288:1999;928-937.